Aortic Aneurysm Clinical Trial
Official title:
Comparative Clinical and Economic Analysis of Percutaneous vs. Open Access for Endovascular Aortic Repair - a Prospective, Randomised Trial.
The present clinical trial is performed in the field of vascular surgery. The aim of the study is the economical and clinical comparison of two different access ways to the femoral artery with intention of endovascular repair of aortic aneurysm. The usual access is a surgical cutdown to the femoral artery and is compared to a percutaneous access which is closed via a suture mediated device (Perclose ProGlide, Abbott).
Introduction:
Endovascular repair of aortic aneurysms (EVAR) is a routine procedure in vascular surgery
and associated with less perioperative complications compared to open aortic repair.
Continuous improvement of endovascular techniques is crucial for sufficient patient care,
especially in elderly with serious comorbidities. Percutaneous access (pEVAR) to the femoral
artery is associated with less wound complications when performed in suitable patients.
Prospective data about economic feasibility and exact duration of the technique itself
compared to the open access during the surgery are missing.
Methods and data collection:
The primary endpoints of this prospective randomised single center trial are cost and time
differences of open vs. percutaneous access. Each Patient enrolled in the study will receive
percutaneous on one side and surgical access on the other side of the groin for femoral
artery access.
The punction site will be closed using the Perclose ProGlide Suture-Mediated Closure System
manufactured by Abbott Vascular. This device works through stiff wire guided delivering of a
monofilament suture to the femoral artery punction site. After finishing endovascular
procedures for aneurysm repair, the thereby laid sutures are tightened to achieve
hemostasis. This system is suitable for sheath sizes up to 21 F (.28 inch).
Open access on the other side is performed with a cutdown to the femoral artery and closure
after finished procedure, with a polypropylene suture.
Patients who undergo endovascular aortic repair at the Department of Vascular Surgery of
Wilhelminenspital Vienna are recruited for the study after informed consent and fulfilled
inclusion criteria. Included are men and women from the age of 18 - 90 years with any
indication for endovascular aneurysm repair (thoracic, infrarenal aortic or iliac artery
aneurysm, or combinations of these). Indication for aneurysm repair is not a part of this
study and is set in accordance to international guidelines. Women in childbearing years
could be included after detailed explanation of special risks for further pregnancy after
EVAR and after proof of negative pregnancy test. Exclusion criteria are occlusive aortic
disease, aneurysm of the femoral artery, diameter < 5mm or severe calcification, patients
with keloided inguinal site, adipositas per magna or demented patients.
Due to a prior power analysis a optimum number of 50 cases was determined. Randomization is
performed by lot (patients draw an envelope which contains either left or right side is done
by pEVAR).
Data is collected preoperatively with a case report form (CRF) including detailed health
information about the patient. During the surgery, femoral artery access and wound closure
time is measured separately for each side (in minutes). Material costs are also documented
separately for each side (in €). Postoperative data about wound healing and pain of each
inguinal side are collected descriptive using the CRF. Data management and analysis is
anonymous using random patient numbers on the forms.
Main targets of the study are cost and time difference of percutaneous and open access
techniques. Possible difference in both groups will be analyzed using the Wilcoxon Signed
Rank Test. Postoperative data will be evaluated descriptively.
In case of cost advantage of the percutaneous access, this study economically legitimates
the use of suture mediated closure systems and therefore contributes to the establishment of
minimally invasive endovascular aortic repair.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04149600 -
Identification of Genetic Causes of Calcific Aortic Valve Disease
|
||
Enrolling by invitation |
NCT04035356 -
HAART Annuloplasty Device Valve Repair Registry
|
||
Recruiting |
NCT02729064 -
Intraoperative Nasal Insulin Effect on Plasma and CSF Insulin Concentration and Blood Glucose
|
Phase 1 | |
Completed |
NCT02467062 -
Implementation of Non-size Markers Derived From 4D Flow MRI of Patients With Aortic Disease.
|
N/A | |
Completed |
NCT02283307 -
Dual Energy CT Urography With Reduced Iodinated Contrast
|
N/A | |
Completed |
NCT01678261 -
X-chromosome Inactivation, Epigenetics and the Transcriptome
|
N/A | |
Terminated |
NCT01055275 -
Cook Iliac Branch Graft Post-market Registry
|
N/A | |
Completed |
NCT00615888 -
Fast Track Management in Elective Open Infrarenal Aortic Aneurysm Repair
|
N/A | |
Completed |
NCT03510793 -
Microcirculation and Anesthesia in Vascular Surgery
|
||
Completed |
NCT03207568 -
RE-GENERATION: The Safety and Performance of the Relay Pro and Relay NBS Pro Stent-graft Devices in the European Union (EU)
|
N/A | |
Recruiting |
NCT05073991 -
Incidence of Mortality and Complications After Lung Surgery, Open Thoracic Aortic Repair, TEVAR, EVAR.
|
||
Not yet recruiting |
NCT01918982 -
Circulating Endothelial Progenitor Cells and Aortic Aneurysm
|
N/A | |
Not yet recruiting |
NCT01918969 -
Reference Values of Circulating Endothelial Progenitor Cells
|
N/A | |
Completed |
NCT02000544 -
Clinical Evaluation of a Modular Extracorporeal Circulation Circuit
|
N/A | |
Completed |
NCT01256372 -
An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery
|
Phase 2 | |
Recruiting |
NCT00661518 -
PET/CT Imaging of Aneurysm Wall Inflammation
|
N/A | |
Completed |
NCT00094575 -
Standard Open Surgery Versus Endovascular Repair of Abdominal Aortic Aneurysm (AAA)
|
Phase 4 | |
Recruiting |
NCT04471909 -
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
|
N/A | |
Recruiting |
NCT05603520 -
Phenotyping Heterogeneity and Regionality of the Aorta
|
||
Completed |
NCT03727542 -
Influence of Short AV Delay Permanent Pacing on Matrix Metalloproteinase Levels
|
N/A |